106
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Correlates of Having Never Been HIV Tested among Entrants to Substance Abuse Treatment Clinics: Empiric Findings from Real-World New England Settings

, Ph.D., M.P.H., , Ph.D., , M.D., M.A. & , Ph.D.

REFERENCES

  • Altice, F.L.; Kamarulzaman, A.; Soriano, V.V.; Schechte, M. & Friedland, G.H. 2010. Treatment of medical, psychiatric, and substance use co-morbidities in people infected with HIV who use drugs. The Lancet 376 (9738): 367–387.
  • Anderson, J.E.; Chandra, A. & Mosher, W. 2005. HIV Testing in the United States, 2002. Advance data from vital statistics. Hyattsville, MD: National Center for Health Statistics.
  • Anderson, J.E. & Sansom, S. 2007. HIV testing in a national sample of pregnant US women: Who is not getting tested? AIDS Care 19 (3): 375–380.
  • Bond, L.; Lauby, J. & Batson, H. 2005. HIV testing and the role of individual and structural-level barriers and facilitators. AIDS Care 17 (2): 125–140.
  • Branson, B.M.; Hansfield, H.H.; Lampe, M.A.; Janssen, R.; Taylor, A.W.; Lyss, S.B. & Clark, J.E. 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report 55 (RR14): 1–17.
  • Castilla, J.; Sobrino, P.; de la Fuente, L.; Noguer, I.; Luis, G. & Parras, F. 2002. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: Consequences for AIDS incidence. AIDS 16 (14): 1945–51.
  • Centers for Disease Control and Prevention. 2008. HIV prevalence estimates: United States 2006. Morbidity and Mortality Weekly Report 57: 1073–1076.
  • Centers for Disease Control and Prevention. 2011. HIV Surveillance: United States from 1981-2008. Morbidity and Mortality Weekly Report 60 (21): 690–693.
  • Darke, S.; Hall, W.; Heather, N.; Ward, J. & Wodak, A. 1991. The reliability and validity of a scale to measure HIV risk-taking behavior among intravenous drug users. AIDS 5 (2): 181–185.
  • Denison, J.A.; O’Reilly, K.R.; Schmid, G.P.; Kennedy, C.E. & Sweat, M.D. 2008. HIV voluntary counseling and testing and behavioral risk reduction in developing countries: A meta-analysis 1990-2005. AIDS and Behavior 12 (3): 363–373.
  • Dybul, M.; Bolan, R.; Condoluci, D.; Cox-Iyamu, R.; Redfield, R.; Hallahan, C.W.; Folino, M.; Sathasivam, K.; Weisberg, M.; Andrews, M.; Hidalgo.; Vasquez, J. & Fauci, A.S. 2002. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus by sex and race in urban settings. Journal of Infectious Diseases 185 (12): 1818–21.
  • Edelman, E.J.; Dinh, A.T.; Moore, B.A.; Schottenfeld, R.S.; Fiellin, D.A. & Sullivan, L.E. 2012. HIV-testing practices among buprenorphine-prescribing physicians. Journal of Addiction Medicine 6 (2): 159–165.
  • First, M.B.; Spitzer, R.L.; Gibbon, M. & Williams, J.B. 1996. Structured Clinical Interview for DSM-IV Axis I Disorders (Clinician Version). Washington, DC: American Psychiatric Press.
  • Gardner, E.M.; McLees, M.P.; Steiner, J.F.; Del Rio, C. & Burman, W.J. 2011. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases 52 (6): 793–800.
  • Guerrero, E.G. & Cederbaum, J.A. 2011. Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. International Journal of Drug Policy 22 (1): 41–48.
  • Hall, H.; Song, R.; Rhodes, P.; Prejean, J.; An, Q.; Lee, L.M.; Karon, J.; Brookmeyer, R.; Kaplan, E.H.; McKenna, M.T. & Janssen, R.S. 2008. Estimation of HIV incidence in the United States. Journal of the American Medical Association 300 (5): 520–529.
  • Inungu, J.N. 2002. Potential barriers to seeking human immunodeficiency virus testing among adults in the United States: Data from the 1998 National Health Interview Survey. AIDS Patient Care and STDs 16 (6): 293–299.
  • Jenness, S.M.; Murrill, C.S.; Liu, K.L.; Wendel, T.; Begier, E. & Hagan, H. 2009. Missed opportunities for HIV testing among high-risk heterosexuals. Sexually Transmitted Diseases 36 (11): 704–710.
  • Kalichman, S.C. & Simbayi, L.C. 2003. HIV testing attitudes, AIDS stigma, and voluntary HIV counseling and testing in a black township in Cape Town, South Africa. Sexually Transmitted Infections 79 (6): 442–447.
  • Kelley, J.L. & Petry, N.M. 2000. HIV risk behaviors in male substance abusers with and without antisocial personality disorder. Journal of Substance Abuse Treatment 19 (1): 59–66.
  • Klein, D.; Hurley, L.B.; Merrill, D. & Quesenberry, C.P. Jr. 2003. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: Implications for early detection. Journal of Acquired Immune Deficiency Syndrome 32 (2): 143–152.
  • Marks, G.; Crepaz, N. & Janssen, R.S. 2006. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20 (10): 1447–1450.
  • Marks, G.; Crepaz, N.; Senterfitt, J.W. & Janssen, R. 2005. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the US: Implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndrome 39 (4): 446–453.
  • McLellan, A.T.; Luborsky, L.; Cacciola, J.; Griffith, J.; Evans, F.; Barr, H.L. & O’Brien, C.P. 1985. New data from the Addiction Severity Index: Reliability and validity in three centers. The Journal of Nervous and Mental Diseases 173 (7): 412–423.
  • Metsch, L.R.; Feaster, D.J.; Gooden, L.; Matheson, T.; Mandler, R.; Haynes, L.; Colfax, G.N. 2012. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: Results of a randomized trial. American Journal of Public Health 102 (6): 1160–1167.
  • Montaner, J.S. 2011. Treatment as prevention—a double hat-trick. The Lancet 378 (9787): 208–209.
  • Montaner, J.S.; Lima, V.D.; Barrios, R.; Yip, B.; Wood, E.; Kerr, T.; Shannon, K.; Harrigan, P.R.; Daly, P. & Kendall, P. 2010. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. The Lancet 376 (9740): 532–539.
  • Nearns, J.; Baldwin, J.A. & Clayton, H. 2009. Social, behavioral, and health care factors associated with recent HIV testing among sexually active non-Hispanic black women in the United States. Women’s Health Issues 19 (1): 52–60.
  • Paltiel, A.D.; Weinstein, M.C.; Kimmel, A.D.; Seage, G.R.; Losina, E.; Zhang, H.; Freedberg, K.A. & Walensky, R. 2005. Expanded screening for HIV in the United States: Analysis of cost-effectiveness. The New England Journal of Medicine 352 (6): 586–595.
  • Petroll, A.E.; DeFranceisco, W.; McAuliffe, T.L.; Seal, D.W.; Kelly, J. & Pinkerton, S. 2008. HIV testing rates, testing locations, and health-care utilization among African-American men. Journal of Urban Health 86 (1): 119–131.
  • Petry, N.M. 2001. Reliability of drug users’ self-reported HIV risk behaviors using a brief, 11-item scale. Substance Use and Misuse 36 (12): 1731–1747.
  • Petry, N.M.; Alessi, S.M.; Carroll, K.M.; Hanson, T.; MacKinnon, S.; Rounsaville, B. & Sierra, S. 2006. Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. Journal of Consulting and Clinical Psychology 74 (3): 592–601.
  • Petry, N.M.; Alessi, S.M.; Marx, J.; Austin, M. & Tardif, M. 2005. Vouchers versus prizes: Contingency management for treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology 73 (6): 1005–1014.
  • Petry, N.M.; Tedford, J.; Austin, M.; Nich, C.; Carroll, K.M. & Rounsaville, B.J. 2004. Prize reinforcement contingency management for treatment of cocaine abusers: How low can we go, and with whom? Addiction 99 (3): 349–360.
  • Petry, N.M.; Weinstock, J. & Alessi, S.M. 2011. A randomized trial of contingency management delivered in the context of group counseling. Journal of Consulting and Clinical Psychology 79 (5): 686–696.
  • Petry, N.M.; Weinstock, J.; Alessi, S.M.; Lewis, M.W & Dieckhaus, K. 2010. Group-based randomized trial of contingencies for health and abstinence in HIV patients. Journal of Consulting and Clinical Psychology 78 (1): 89–97.
  • Pollack, H.A. & D’Aunno, T. 2010. HIV testing and counseling in the nation’s outpatient substance abuse treatment system 1995–2005. Journal of Substance Abuse Treatment 38 (4): 307–316.
  • Prejean, J.; Song, R.; Hernandez, A.; Ziebell, R.; Green, T.; Walker, F.; Lin, L.S.; An, Q.; Mermin, J.; Lansky, A. & Hall, H.I. 2011. Estimated HIV incidence in the United States, 2006–2009. PLoS ONE 6 (8): 175–182.
  • Robinson, K.; Sanders, S.A. & Boyd, J.L. 2012. High-risk HIV minorities in the United States: Who gets tested and where? American Journal of Health Behavior 36 (3): 348–359.
  • Rountree, M.A.; Chen, L. & Brown, A. 2009. HIV testing rates and locations by race and ethnicity. Health and Social Work 34 (4): 247–255.
  • Substance Abuse and Mental Health Services Administration. 2010. The N-SSATS Report: Infectious Disease Screening. Rockville, MD: SAMHSA.
  • Substance Abuse and Mental Health Services Administration. 2011. Rapid HIV Testing in Substance Abuse Treatment Facilities, Advisory 10. Rockville, MD: SAMHSA.
  • Substance Abuse and Mental Health Services Administration. 2012. National Survey of Substance Abuse Treatment Services (N-SSATS): 2011. Data on Substance Abuse Treatment Facilities. BHSIS Series S-64, HHS Publication No. (SMA) 12-4730. Rockville, MD: SAMHSA.
  • Volkow, N.D. & Montaner, J.S. 2011. Enhanced HIV testing, treatment, and support for HIV-infected substance users. Journal of the American Medical Association 303 (14): 1423–1424.
  • Wenzel, S.; Rhoades, H.; Tucker, J.S.; Golinelli, D.; Kennedy, D.P.; Zhou, A. & Ewing, B. 2012. HIV risk behavior and access to services: What predicts HIV testing among heterosexually active homeless men? AIDS Education and Prevention 24 (3): 270–279.
  • Winstanley, E.L.; Gust, S.W. & Strathdee, S.A. 2006. Drug abuse and HIV/AIDS: International lessons and imperatives. Drug and Alcohol Dependence 82: S1–S5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.